Alnylam Pharmaceuticals, Inc. <ALNY.O>: Wells Fargo cuts target price to $316 from $377
ALNY•Related News
Anglogold Ashanti Says Guidance On Track With An Improved H2 2026
AU•
IRadimed Q2 profit rises on record monitor bookings
IRMD•
Everus To Acquire Epsilon Industries, Premier Off-Site Modular Construction Solutions Provider
ECG•
Co-Diagnostics holders exercise 1,702,362 warrants at USD 1.57 per share in inducement deal
CODX•
Ridgetech FY26 net loss widens to $1.25 million; revenue rises 10.2% to $132.16 million
RDGT•